Edition:
Deutschland

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

68.96EUR
17:35 Uhr
Change (% chg)

€1.54 (+2.28%)
Prev Close
€67.42
Open
€67.54
Day's High
€69.02
Day's Low
€67.48
Volume
1,229,579
Avg. Vol
1,299,970
52-wk High
€72.76
52-wk Low
€58.96

FREG.DE

Chart for FREG.DE

About

Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes... (more)

Buy/Sell

Sell Hold Buy
2.00 Mean rating from 23 analysts

Overall

Beta: 0.56
Market Cap(Mil.): €39,028.29
Shares Outstanding(Mil.): 554.54
Dividend: 0.62
Yield (%): 0.88
Photo

Trade pact lifts European shares while Italy extends slide

LONDON European shares rose on Monday as a new U.S.-Mexico-Canada trade pact lifted some of the gloom over global trade, while Italian stocks extended Friday's slide as top EU officials weighed in on the government's budget plans.

UPDATE 2-Trade pact lifts European shares while Italy extends slide

* Fresenius jumps 8.5 pct after Akorn ruling win (Updates prices, adds details)

Delaware judge says Fresenius can walk away from $4.8 billion Akorn deal

WILMINGTON, Del Germany's Fresenius SE won a rare court ruling allowing the healthcare group to walk away from its $4.75 billion takeover of Akorn Inc , sparking a more than 50 percent fall in the U.S. generic drugmaker's shares.

Delaware judge says Fresenius can walk away from $4.8 billion Akorn deal

WILMINGTON, Del Germany's Fresenius SE won a rare court ruling allowing the healthcare group to walk away from its $4.75 billion takeover of Akorn Inc , sparking a more than 50 percent fall in the U.S. generic drugmaker's shares.

REFILE-UPDATE 2-Delaware judge says Fresenius can walk away from $4.8 bln Akorn deal

WILMINGTON, Del, Oct 1 Germany's Fresenius SE won a rare court ruling allowing the healthcare group to walk away from its $4.75 billion takeover of Akorn Inc , sparking a more than 50 percent fall in the U.S. generic drugmaker's shares.

Judge rules for Fresenius in bid to end $4.8 bln Akorn deal

WILMINGTON, Del, Oct 1 A Delaware judge ruled on Monday that German healthcare group Fresenius SE could walk away from its $4.75 billion deal for U.S. drugmaker Akorn Inc and rejected Akorn's claim that the merger agreement had been breached.

Fresenius shares jump on report of win in Akorn ruling

LONDON Shares in German healthcare group Fresenius surged up 9.3 percent on Monday after a Bloomberg report that the firm won a ruling to pull out of a $4.3 billion deal to buy U.S. generic pharmaceuticals company Akorn .

German stocks - Factors to watch on Sept. 25

BERLIN, Sept 25 The following are some of the factors that may move German stocks on Tuesday:

German stocks - Factors to watch on August 24

BERLIN, Aug 24 The following are some of the factors that may move German stocks on Friday:

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie +1.29%
Rohstoffe +1.66%
Industrie +1.88%
Konjunktur abhängige Waren & Dienstleistungen +0.71%
Konjunktur unabhängige Waren & Dienstleistungen +1.35%
Finanzindustrie +2.62%
Pharma +2.96%
Technologie +1.05%
Telekommunikation +1.30%